Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Obesity results in adipose tissue T cell exhaustion
Cara E. Porsche, Jennifer B. Delproposto, Lynn Geletka, Robert O’Rourke, Carey N. Lumeng
Cara E. Porsche, Jennifer B. Delproposto, Lynn Geletka, Robert O’Rourke, Carey N. Lumeng
View: Text | PDF
Research Article Inflammation Metabolism

Obesity results in adipose tissue T cell exhaustion

  • Text
  • PDF
Abstract

Despite studies implicating adipose tissue T cells (ATT) in the initiation and persistence of adipose tissue inflammation, fundamental gaps in knowledge regarding ATT function impedes progress toward understanding how obesity influences adaptive immunity. We hypothesized that ATT activation and function would have tissue-resident–specific properties and that obesity would potentiate their inflammatory properties. We assessed ATT activation and inflammatory potential within mouse and human stromal vascular fraction (SVF). Surprisingly, murine and human ATTs from obese visceral white adipose tissue exhibited impaired inflammatory characteristics upon stimulation. Both environmental and cell-intrinsic factors are implicated in ATT dysfunction. Soluble factors from obese SVF inhibit ATT activation. Additionally, chronic signaling from macrophage major histocompatibility complex II (MHCII) is necessary for ATT impairment in obese adipose tissue but is independent of increased PD1 expression. To assess intracellular signaling mechanisms responsible for ATT inflammation impairments, single-cell RNA sequencing of ATTs was performed. ATTs in obese adipose tissue exhibit enrichment of genes characteristic of T cell exhaustion and increased expression of coinhibitory receptor Btla. In sum, this work suggests that obesity-induced ATTs have functional characteristics and gene expression resembling T cell exhaustion induced by local soluble factors and cell-to-cell interactions in adipose tissue.

Authors

Cara E. Porsche, Jennifer B. Delproposto, Lynn Geletka, Robert O’Rourke, Carey N. Lumeng

×

Figure 6

PD1 blockade does not reverse ATT impairment.

Options: View larger image (or click on image) Download as PowerPoint
PD1 blockade does not reverse ATT impairment.
(A) Schematic of in vivo P...
(A) Schematic of in vivo PD1 blockade timeline and interventions. (B) Glucose tolerance test of ND- and HFD-fed mice after administration of αPD1 or IgG2a isotype injections (left) and glucose levels after fasting for 6 hours (right). n = 4 biological replicates/group, analyzed by 2-way ANOVA where *P < 0.05, **P < 0.01. (C and D) ATT activation assays were performed on eWAT SVF and splenocytes after PD1 blockade regimen. Frequency of CD25 expression on CD8+ T cells and Tconv measured 3 days after Dynabead stimulation. n = 4 biological replicates/group, analyzed by 2-way ANOVA where *P < 0.05, **P < 0.01, ****P < 0.0001. (E and F) IL-2 and IFN-γ concentration in culture supernatants from PD1 blockade ATT activation assays of eWAT SVF and splenocytes. n = 4 biological replicates/group, analyzed by 2-way ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts